The better performance of serum NSE concentrations for neurological prognostication in younger cardiac arrest patients has already been described in a previously mentioned Finnish cohort study by Wihersaari et al. that included unconscious OHCA patients and NSE measurements at 48 h [20]. The gene discussed is ENO2; the disease is cardiac arrest.